Board of Directors
Swiss (born 1964)
Chairman of the Board since 2010
Board Member since 2009
Other current activities:
Member of the Board of Ypsomed (Member of Compensation Committee), Member of the Board of Vifor Pharma (Audit Committee Chair), Member of the Board of Julius Bär Group (Nomination Committee Chair), Committee Member of the Basel Chamber of Commerce, Board Member of the ITI1; Supervisory Board Member of IMD Business School, Lausanne; Juror at VentureKick and Business Angel.
In previous years, Gilbert Achermann served as Chairman and Co-CEO of the Vitra Group, a family-owned furniture and retail company; Chairman of the Siegfried Group, a listed pharma service company, and Vice Chairman of the Moser Group, a privately owned luxury watchmaking company. From 2002 to 2010, he was CEO of Straumann, which he joined as CFO in 1998. He started his professional life at UBS in Investment Banking in 1988.
Executive MBA from IMD; Bachelor’s degree from the University of Applied Science (HWV) in St. Gallen.
Key attributes for the Board:
Key attributes for the Board: Mr Achermann represents continuity, stability and credibility among the various stakeholders. The Board benefits from his extensive knowledge of the dental industry as well as the deep experience and insight gained from directorships in other industries.
1 For relationship with Straumann see Note 9.4 on p. 180 of the Annual Report 2019.